RECRUITING

Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.

Official Title

Fall Risk and Quality of Life: Influence of Dual Task Performance, Cognition, and Sensorimotor Variables in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Quick Facts

Study Start:2024-03-30
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06313359

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Individuals 18 years and older
  2. * diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms.
  3. * age (+/- one year) and gender matched individuals
  4. * no diagnosed peripheral neuropathy
  5. * No diagnosed cognitive symptoms.
  1. * Unable to follow two step commands.
  2. * Unable to ambulate x 50 feet independently without use of an assistive device.
  3. * Unable to use a phone to send text messages.
  4. * Diagnosis of diabetic peripheral neuropathy
  5. * Diagnosis of CNS cancer.
  6. * Unable to speak/understand English

Contacts and Locations

Study Contact

Priya Karakkattil
CONTACT
12148625624
Pkarakkattil@twu.edu

Principal Investigator

Priya Karakkattil, PhD
PRINCIPAL_INVESTIGATOR
Texas Woman's University
Asha Vas, PhD
PRINCIPAL_INVESTIGATOR
Texas Woman's University

Study Locations (Sites)

Texas Woman's University
Dallas, Texas, 75235
United States

Collaborators and Investigators

Sponsor: Texas Woman's University

  • Priya Karakkattil, PhD, PRINCIPAL_INVESTIGATOR, Texas Woman's University
  • Asha Vas, PhD, PRINCIPAL_INVESTIGATOR, Texas Woman's University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-30
Study Completion Date2025-06

Study Record Updates

Study Start Date2024-03-30
Study Completion Date2025-06

Terms related to this study

Additional Relevant MeSH Terms

  • Peripheral Neuropathy Due to Chemotherapy